# A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

> **NCT01001299** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 25 (actual)

## Conditions studied

- Malignant Melanoma

## Interventions

- **DRUG:** Drug cocktail
- **DRUG:** RO5185426

## Key facts

- **NCT ID:** NCT01001299
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-30
- **Primary completion:** 2012-02-29
- **Final completion:** 2012-02-29
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001299, "A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01001299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*